Locoregional Therapy for HCC: Review Recent Advances in Tumor Ablation for Hepatocellular Carcinoma

Image-guided tumor ablation for early stage hepatocellular carcinoma (HCC) is an accepted non-surgical treatment that provides excellent local tumor control and favorable survival benefit. This review summarizes the recent advances in tumor ablation for HCC. Diagnostic imaging and molecular biology of HCC has recently undergone marked improvements. Second-generation ultrasonography (US) contrast agents, new computed tomography (CT) techniques, and liver-specific contrast agents for magnetic resonance imaging (MRI) have enabled the early detection of smaller and inconspicuous HCC lesions. Various imaging-guidance tools that incorporate imaging-fusion between real-time US and CT/MRI, that are now common for percutaneous tumor ablation, have increased operator confidence in the accurate targeting of technically difficult tumors. In addition to radiofrequency ablation (RFA), various therapeutic modalities including microwave ablation, irreversible electroporation, and high-intensity focused ultrasound ablation have attracted attention as alternative energy sources for effective locoregional treatment of HCC. In addition, combined treatment with RFA and chemoembolization or molecular agents may be able to overcome the limitation of advanced or large tumors. Finally, understanding of the biological mechanisms and advances in therapy associated with tumor ablation will be important for successful tumor control. All these advances in tumor ablation for HCC will result in significant improvement in the prognosis of HCC patients. In this review, we primarily focus on recent advances in molecular tumor biology, diagnosis, imaging-guidance tools, and therapeutic modalities, and refer to the current status and future perspectives for tumor ablation for HCC. Copyright © 2015 S. Karger AG, Basel © 2015 S. Karger AG, Basel 2235-1795/15/0043-0176$39.50/0 www.karger.com/lic Liver Cancer 2015;4:176–187 DOI: 10.1159/000367740 Published online: July 17, 2015 Hyunchul Rhim, MD Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine 50 Irwon-Dong, Gangnam-gu, Seoul 135-710 (Republic of Korea) Tel. +82 2 341